source
- FDA approves generic lenacapavir for low-income markets; EMA to review Lundbeck's Deanxit over safety concernsThe U.S. Food and Drug Administration has granted approval for a generic version of lenacapavir, a drug aimed at treating HIV, with the intention of making it available to lower-income countries.…
- Midterm voters weigh health-care costs as urgent-care visits billed like ERsThe upcoming midterm elections will see tens of millions of voters consider health‑care affordability, especially those whose coverage comes through their employers. The article points out that ri…